Clearside Biomedical/ US1850631045 /
| 2024-05-03 9:59:30 PM | Chg. 0.00 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.32USD | 0.00% | 325 Turnover: 428.76 |
-Bid Size: - | -Ask Size: - | 1.34 | 1.30 |
GlobeNewswire
04-30
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on ...
GlobeNewswire
04-16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
04-02
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare C...
GlobeNewswire
03-12
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corp...
GlobeNewswire
02-29
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corpo...
GlobeNewswire
02-26
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
GlobeNewswire
02-07
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
GlobeNewswire
2023-12-14
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
GlobeNewswire
2023-11-13
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-08
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
GlobeNewswire
2023-11-07
Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic In...
GlobeNewswire
2023-11-03
BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema...
GlobeNewswire
2023-11-02
Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Me...
GlobeNewswire
2023-11-01
Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
GlobeNewswire
2023-10-31
Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on ...
GlobeNewswire
2023-10-16
Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th An...
GlobeNewswire
2023-10-04
Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment o...
GlobeNewswire
2023-10-03
Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit
GlobeNewswire
2023-09-19
Clearside Biomedical to Participate in Panel Discussion at the Cantor Global Healthcare Conference
GlobeNewswire
2022-03-10
Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corp...
GlobeNewswire
2022-03-03
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
GlobeNewswire
2022-03-01
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2022
